India and Vietnam Near BrahMos Missile Deal Implications for Defense Sector and Regional Security IntermediateTerm Technical Outlook Turns Bullish What Investors Should Know OpenAIs Potential IPO Valuation Trends and Key Risks to Watch Morgan Stanley Lifts Devon Energy Price Target by 7 Signaling Confidence in EP Sector Fintech Firm Mercury Reaches 52 Billion Valuation After 200 Million Funding Round ReadytoDrink Cocktails Continue to Drive Alcohol Industry Growth in 2026 Bar Harbor Bankshares Inc BHB Q1 2026 Earnings EPS Misses Estimates as Net Interest Margin Faces Pressure NGNE Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment MGPI Q1 2026 Earnings Significant EPS Beat Bolstered by Operational Efficiency Cheetah Mobile CMCM Q4 2025 Earnings Loss Per ADS of 110 Stock Declines 35 RBLX Q1 2026 Earnings EPS Surprise of 3531 Beats Estimates Despite Loss Live Ventures Slips Again Support Level at 101 Holds the Key for a Potential Reversal Hesai Group HSAI Slips 129 as Lidar Sector Faces Headwinds Support at 196 Under Watch ON Semiconductor Surges 6 as Bulls Test Key Resistance Zone Kearny Financial Holds Near 820 as Small Decline Keeps Shares in Tight Range Flaherty Crumrine Preferred Income Opportunity Fund PFO Edges Higher Amid Steady Trading Bitcoin Slips to 75000 as Crypto Diverges from Tech Stock Momentum EE Q1 2026 Earnings EPS Misses Estimates Yet Shares Rise on Steady Operations Anavex Life Sciences AVXL Edges Higher Amid Biotech Sector Rotation RCI Hospitality Holdings Q3 2025 Earnings Deep EPS Miss Amidst Operating Headwinds Tucows Inc TCX Q1 2026 Earnings Negative EPS Reflects Ongoing Investment Phase Amid Stock Stagnation ECCW Q4 2025 Earnings EPS Beats Estimates by 138 Stock Nearly Flat Energizer Holdings Q1 2026 Earnings EPS Crushes Estimates by Over 100 as Cost Initiatives Drive Profitability Pure Cycle Corporation PCYO Q1 2026 Earnings Modest Profit Reported Amid Flat Revenue TXO Partners Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Challenges TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline